Skip to main content
. 2020 Jun 30;13:6245–6253. doi: 10.2147/OTT.S241231

Table 2.

Co-Mutation Between MET Ex14 Skipping and EGFR/KRAS/ALK/ROS1/RET in NSCLC and ADC Populations

NSCLC ADC
N MET ex14- MET ex14 + N MET ex14- MET ex14+
EGFR mut 444 443 1 (0.2%) 425 424 1 (0.2%)
KRAS mut 99 99 0 89 89 0
ALK 52 52 0 50 50 0
ROS1 13 13 0 11 11 0
RET 10 10 0 10 10 0
Quintuple-negative 340 324 16 (4.7%) 196 183 13 (6.6%)